Key result
Light-chain cardiac amyloidosis carries high cardioembolic risk regardless of sinus rhythm, warranting transoesophageal echocardiography.
Why the study?
The high risk of cardioembolic events in light-chain cardiac amyloidosis (AL-CA) despite sinus rhythm and the lack of formal recommendations for anticoagulation management motivated this study.
May warrant TEE screening in light-chain amyloidosis irrespective of rhythm; leaves open prospective validation of clinical impact.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Giampatzis et al. (2023) conducted an editorial in Light-chain cardiac amyloidosis (AL-CA). Cardioembolic risk in light-chain cardiac amyloidosis is high irrespective of sinus rhythm, requiring rigorous assessment for intracardiac thrombi using transoesophageal echocardiography.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: